JCCC research seminar featuring Dr. Erika von Euw
PARP inhibition potentiates low dose temozolomide in cancer cell lines
- Date: February 23, 2017 12:00 PM - 1:00 PM
- Location: 53-105 CHS
Los Angeles, California 90095
Erika von Euw, Ph.D.
Assistant Professor, Department of Medicine, Hematology/Oncology
Member, JCCC Signal Transduction and Therapeutics Program
Dr. Erika von Euw’s primary focus is on translational cancer research. She is developing a program that advances the discovery of novel therapeutic projects by combining the scientific strengths of the investigators in the Translational Oncology Research Laboratory with the business knowledge of former industry professionals now at UCLA to discover new therapeutic targets for cancer treatment. Her goal is to develop ADC (Antibody Drug Conjugates), rnAb (monoclonal Antibody) or small molecules with the potential to bring better targeted therapies to cancer patients and improve patient survival.
Light lunch served
Sponsored by UCLA's Jonsson Comprehensive Cancer Center Signal Transduction and Therapeutics program